Neuronal Acetylcholine Receptor Subunit Alpha 7 Pipeline Review, H2 2019 – Therapy Areas Covered Such as Central Nervous System, Cardiovascular, Immunology, Metabolic Disorders and Oncology – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Neuronal Acetylcholine Receptor Subunit Alpha 7 – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) pipeline Target constitutes close to 16 molecules. Out of which approximately 14 molecules are developed by companies and remaining by the universities/institutes. The latest report Neuronal Acetylcholine … [Read more…]
